GeNeuro is looking for new partners
GeNeuro is looking for growing. Partnering and licensing activities are key elements to support GeNeuro’s growth strategy. These partnering activities should consolidate the core business of GeNeuro in the field of endogenous retrovirus associated disorders and neuro-inflammatory and autoimmune diseases.
To create the optimal conditions for the successful development of its therapeutic products, GeNeuro plans to out-license its products.
Similarly, to reinforce its portfolio, GeNeuro is also seeking to in-license additional assets which can complement its innovative approach.
For any interest in investment and licensing deals with GeNeuro, please contact us at: contact@geneuro.com